Two research teams at Leiden University have secured over €1 million in funding through the NACTAR programme (Dutch Research Agenda) to explore innovative solutions to antimicrobial resistance (AMR).
Led by Prof. Gilles van Wezel, the first project focuses on unlocking hidden antibiotics from soil bacteria using advanced genome-editing tools. The second, led by Dr. Karina Xavier in collaboration with Wageningen University, investigates how gut microbes can be used to prevent infections by outcompeting harmful bacteria.
Both projects reflect the interdisciplinary strength of the Leiden Bio Science Park and aim to contribute to safer, more effective alternatives to traditional antibiotics.
“These projects show how our research ecosystem is driving solutions to critical global challenges,” said an LBSP spokesperson.
Read more on the Leiden University website.
VarmX, a biotechnology company based at the Leiden Bio Science Park (LBSP), has entered into a strategic collaboration and option agreement with global biotechnology leader CSL...
Leiden University Medical Center (LUMC), via its Cairelab initiative, together with the Dutch Police, have been declared winners of the National AI Challenge 2025, organized by...
Marieke Vinkenoog and Simon Christian Hansmann have been awarded the Krijn Rietveld Memorial Innovation Awards for their research in blood donation and colorectal cancer. Vinkenoog’s work on predictive modeling for donor eligibility and Hansmann’s identification of cancer cells linked to tumor recurrence exemplify the integration of advanced scientific methods to address pressing health challenges.